Report cover image

Carmell Therapeutics Corp - Product Pipeline Analysis, 2022 Update

Publisher GlobalData
Published Feb 07, 2023
Length 38 Pages
SKU # GBDT17776270

Description

Summary

Carmell Therapeutics Corp (Carmell) is a biotechnology company which develops and commercializes plasma-based bio-active materials (PBMs). Its product pipeline includes bone healing accelerant for treatment of long bone fractures, shoulder repair, spine fusion and total joint replacement; and tissue healing accelerant against surgical wounds, partial and full thickness grafts and primary healing in chronic wound beds. The company utilizes its PBM technology platform, which cross links lyophilized plasma into solid and semi-solid plasma-based materials, to treat wounds and reduce infections. It develops products in the therapeutic areas of orthopedics, soft tissue healing, burns and dermatology. Carmell is headquartered in Pittsburgh, Pennsylvania, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Carmell Therapeutics Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

38 Pages
Carmell Therapeutics Corp Company Overview
Carmell Therapeutics Corp Company Snapshot
Carmell Therapeutics Corp Pipeline Products and Ongoing Clinical Trials Overview
Carmell Therapeutics Corp – Pipeline Analysis Overview
Carmell Therapeutics Corp - Key Facts
Carmell Therapeutics Corp - Major Products and Services
Carmell Therapeutics Corp Pipeline Products by Development Stage
Carmell Therapeutics Corp Ongoing Clinical Trials by Trial Status
Carmell Therapeutics Corp Pipeline Products Overview
Bone Healing Accelerant - DBM Spine
Bone Healing Accelerant - DBM Spine Product Overview
Bone Healing Accelerant - Foot/Ankle Fusion
Bone Healing Accelerant - Foot/Ankle Fusion Product Overview
Bone Healing Accelerant - Foot/Ankle Fusion Clinical Trial
Bone Healing Accelerant - Long Bone (Tibia) Fractures
Bone Healing Accelerant - Long Bone (Tibia) Fractures Product Overview
Bone Healing Accelerant - Long Bone (Tibia) Fractures Clinical Trial
Bone Healing Accelerant - Shoulder Repair
Bone Healing Accelerant - Shoulder Repair Product Overview
Bone Healing Accelerant - Total Joint Replacement
Bone Healing Accelerant - Total Joint Replacement Product Overview
REPAIR Surgical Scaffold
REPAIR Surgical Scaffold Product Overview
Tissue Healing Accelerant - C-Section/Hysterectomy
Tissue Healing Accelerant - C-Section/Hysterectomy Product Overview
Tissue Healing Accelerant - Chronic Wound Beds
Tissue Healing Accelerant - Chronic Wound Beds Product Overview
Tissue Healing Accelerant - Colorectal Surgery
Tissue Healing Accelerant - Colorectal Surgery Product Overview
Tissue Healing Accelerant - Partial And Full Thickness Grafts
Tissue Healing Accelerant - Partial And Full Thickness Grafts Product Overview
Tissue Healing Accelerant - Sternotomy
Tissue Healing Accelerant - Sternotomy Product Overview
Tissue Healing Accelerant - Surgical Wound Healing
Tissue Healing Accelerant - Surgical Wound Healing Product Overview
Carmell Therapeutics Corp - Key Competitors
Carmell Therapeutics Corp - Key Employees
Carmell Therapeutics Corp - Locations And Subsidiaries
Head Office
Recent Developments
Carmell Therapeutics Corp, Recent Developments
Jan 07, 2020: Carmell Therapeutics receives IND clearance for CT-101, bone healing accelerant
Mar 07, 2019: Carmell Therapeutics announces publication of results of pre-clinical studies on its tissue healing accelerant for the treatment of cutaneous radiation injury
Feb 04, 2019: Carmell Therapeutics to present at the 21st Annual BIO CEO & Investor Conference in New York
Jan 03, 2019: Carmell Therapeutics names Wendy F. Dicicco as board director
Dec 20, 2018: Carmell Therapeutics president & CEO, Randy Hubbell, to present at Biotech Showcase 2019 in San Francisco
Jun 22, 2017: Carmell Therapeutics announced the issuance of Canadian Patent No. 2701187 for Methods and Apparatus for Manufacturing Plasma Based Plastics
May 09, 2017: Carmell Therapeutics expands manufacturing capabilities to support Phase III clinical trials
Oct 05, 2016: Carmell Therapeutics New Management Team
Jun 24, 2016: Carmell announces the awarding of a new U.S. Patent that covers the use of the Company’s plasma-based materials as drug delivery vehicles
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Carmell Therapeutics Corp Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Carmell Therapeutics Corp Pipeline Products by Equipment Type
Table 3: Carmell Therapeutics Corp Pipeline Products by Indication
Table 4: Carmell Therapeutics Corp, Key Facts
Table 5: Carmell Therapeutics Corp, Major Products and Services
Table 6: Carmell Therapeutics Corp Number of Pipeline Products by Development Stage
Table 7: Carmell Therapeutics Corp Pipeline Products Summary by Development Stage
Table 8: Carmell Therapeutics Corp Ongoing Clinical Trials by Trial Status
Table 9: Carmell Therapeutics Corp Ongoing Clinical Trials Summary
Table 10: Bone Healing Accelerant - DBM Spine - Product Status
Table 11: Bone Healing Accelerant - DBM Spine - Product Description
Table 12: Bone Healing Accelerant - Foot/Ankle Fusion - Product Status
Table 13: Bone Healing Accelerant - Foot/Ankle Fusion - Product Description
Table 14: Bone Healing Accelerant - Foot/Ankle Fusion - A Study to Evaluate the Safety and Efficacy of the Bone Healing Accelerant
Table 15: Bone Healing Accelerant - Long Bone (Tibia) Fractures - Product Status
Table 16: Bone Healing Accelerant - Long Bone (Tibia) Fractures - Product Description
Table 17: Bone Healing Accelerant - Long Bone (Tibia) Fractures - A Multiregion, Randomized, Controlled, Blinded Study of the Safety and Efficacy of Bone Healing Accelerant Versus Standard of Care in Subjects with Open Tibia Fractures
Table 18: Bone Healing Accelerant - Shoulder Repair - Product Status
Table 19: Bone Healing Accelerant - Shoulder Repair - Product Description
Table 20: Bone Healing Accelerant - Total Joint Replacement - Product Status
Table 21: Bone Healing Accelerant - Total Joint Replacement - Product Description
Table 22: REPAIR Surgical Scaffold - Product Status
Table 23: REPAIR Surgical Scaffold - Product Description
Table 24: Tissue Healing Accelerant - C-Section/Hysterectomy - Product Status
Table 25: Tissue Healing Accelerant - C-Section/Hysterectomy - Product Description
Table 26: Tissue Healing Accelerant - Chronic Wound Beds - Product Status
Table 27: Tissue Healing Accelerant - Chronic Wound Beds - Product Description
Table 28: Tissue Healing Accelerant - Colorectal Surgery - Product Status
Table 29: Tissue Healing Accelerant - Colorectal Surgery - Product Description
Table 30: Tissue Healing Accelerant - Partial And Full Thickness Grafts - Product Status
Table 31: Tissue Healing Accelerant - Partial And Full Thickness Grafts - Product Description
Table 32: Tissue Healing Accelerant - Sternotomy - Product Status
Table 33: Tissue Healing Accelerant - Sternotomy - Product Description
Table 34: Tissue Healing Accelerant - Surgical Wound Healing - Product Status
Table 35: Tissue Healing Accelerant - Surgical Wound Healing - Product Description
Table 36: Carmell Therapeutics Corp, Key Employees
Table 37: Glossary
List of Figures
Figure 1: Carmell Therapeutics Corp Pipeline Products by Equipment Type
Figure 2: Carmell Therapeutics Corp Pipeline Products by Development Stage
Figure 3: Carmell Therapeutics Corp Ongoing Clinical Trials by Trial Status

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us